Results 111 to 120 of about 20,575,683 (284)
Review on Solubility enhancement of Metoclopramide base by solid dispersion technique for Transdermal drug delivery system [PDF]
Modern drug discovery has led to the development of drug molecules that exhibit high lipophilicity and poor water solubility, which leads to problematic bioavailability.
Sengupta, Riyanka +4 more
core +1 more source
Gallic-Acid-Loaded PLGA Nanoparticles: A Promising Transdermal Drug Delivery System with Antioxidant and Antimicrobial Agents. [PDF]
Aldawsari MF +6 more
europepmc +1 more source
Novel PLA@Fe3O4 magnetic microspheres were developed for transarterial magnetic hyperthermia ablation (MTA) of hepatocellular carcinoma. While destroying local tumors and inducing immunogenic cell death (ICD), MTA combined with early CpG adjuvant administration significantly promotes cDC1‐dependent immune priming. This synergistic mechanism effectively
Jiakun Yang +8 more
wiley +1 more source
A Novel Integrated Transdermal Drug Delivery System with Micropump and Microneedle Made from Polymers. [PDF]
Attiguppe AP, Chatterjee D, DasGupta A.
europepmc +1 more source
A REVIEW ON TRANSDERMAL DRUG DELIVERY SYSTEM
Recently delivery of drugs through the skin is being a challenging area for research because of barrier properties exhibit by the outermost layer of skin stratum corneum.
Prof. Madhuri T. Deshmukh, Harshada A. Lawale *, Prof. R.V. Shete, Prof. R.S. Solunke
core +1 more source
A biomimetic ultrasound‐responsive piRNA delivery nanoparticle platform (piR‐NPs) enables targeted delivery and ultrasound (US)‐triggered release of piR‐1873 in infarcted myocardium. The released piR‐1873 suppresses Usp2‐mediated RIP1/RIP3/MLKL necroptosis, reduces myocardial injury and fibrosis, and promotes cardiac functional recovery, providing a ...
Yajun Zhang +10 more
wiley +1 more source
Losartan Potassium and Verapamil Hydrochloride Compound Transdermal Drug Delivery System: Formulation and Characterization. [PDF]
Chen YS +5 more
europepmc +1 more source
ETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM [PDF]
Skin acts as a major target as well as a principal barrier for topical/transdermal drug delivery. Despite the many advantages of this system, the major obstacle is the low diffusion rate of drugs across the stratum corneum.
Dutt, Rajeswar, KUMAR.CH, ANANDA
core +1 more source
Postoperative arteriovenous fistulas exhibit increased RBMS1 in vascular smooth muscle cells (VSMCs). In experimental AVFs, RBMS1 overexpression aggravates, whereas deletion attenuates, neointimal hyperplasia. RBMS1 binds MPZL1 mRNA and promotes exon 5 skipping to generate MPZL1‐Δ5, which interacts with G3BP1 to activate AKT, driving VSMC proliferation,
Zongda Li +14 more
wiley +1 more source
Background: To develop and optimize Upadacitinib-loaded transdermal patches for rheumatoid arthritis treatment with improved patient compliance and sustained drug delivery.
Shubham Talole +3 more
doaj +1 more source

